03:27 AM EDT, 08/28/2024 (MT Newswires) -- Adam S Grossman, Director, President and Chief Executive Officer, on August 26, 2024, sold 626,245 shares in Adma Biologics ( ADMA ) for $10,923,987. Following the Form 4 filing with the SEC, Grossman has control over a total of 3,784,109 shares of the company, with 2,059,726 shares held directly and 1,724,383 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1368514/000114036124038772/xslF345X05/form4.xml

Price: 17.47, Change: +0.12, Percent Change: +0.69